Elyse Stock, Chief Medical Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 800 shares at $45.01 ($36K) on 2019-10-15, disclosed to the SEC on 2019-10-17.
Scheduled sale ($36k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BHVN | SELL | 2019-10-25 | $798K | — | Filing → |